Strides Pharma Records Q4 Profit, Announces Major Leadership Rejig

Strides Pharma Science Ltd reported a consolidated net profit of Rs 10.44 crore for Q4 ending March 2024, reversing a net loss of Rs 13.79 crore a year ago. The company also announced significant top management changes and achieved its highest-ever annual revenue, driven by growth in the US market.

Related Keywords

Badree Komandur ,Barun Kumar ,Surabhi Loshali ,Aditya Kumar ,Strides Pharma Science Ltd On ,Business Development ,Strides Pharma Science Ltd ,Executive Chairperson ,Managing Director Arun Kumar ,Executive Director Finance ,Strides Pharma Science ,Vice President ,Executive Director ,Avikesh Kumar ,End Markets ,Investor Relations Officer ,Senior Vice President ,Strides Pharma Founder ,